Results 171 to 180 of about 12,078 (208)
An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases
Forensic Science International, 2008 Udgivelsesdato: 2008/5/20We present an oxcarbazepine-related fatality together with an overview of 26 postmortem cases involving oxcarbazepine observed during the period 2001-2006.
Kristian Linnet
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Expert Opinion on Pharmacotherapy, 2002
Oxcarbazepine is one of the recently introduced anti-epileptic drugs (AEDs) in the US. This drug has demonstrated efficacy as adjunctive therapy in adults and children, and as monotherapy in adults for the treatment of seizures of partial onset. There is also convincing evidence of its efficacy in patients with newly diagnosed and refractory trigeminal
Ahmad, Beydoun, Ekrem, Kutluay
openaire +2 more sources
Oxcarbazepine is one of the recently introduced anti-epileptic drugs (AEDs) in the US. This drug has demonstrated efficacy as adjunctive therapy in adults and children, and as monotherapy in adults for the treatment of seizures of partial onset. There is also convincing evidence of its efficacy in patients with newly diagnosed and refractory trigeminal
Ahmad, Beydoun, Ekrem, Kutluay
openaire +2 more sources
Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects [PDF]
European Journal of Pharmaceutical Sciences, 2017 Oxcarbazepine is indicated for the treatment of partial or generalised tonic-clonic seizures. Most of the absorbed oxcarbazepine is converted into its active metabolite, 10-hydroxycarbazepine (MHD), which can exist as R-(-)- and S-(+)-MHD enantiomers ...
Vera Lucia Lanchote +2 more
exaly +1 more source